Bottom line
Is PVIVX a good fund? The bottom line
PVIVX is an actively managed small-cap mutual fund from Paradigm.
Its expense ratio is 1.26% — about $126 a year on every $10,000 invested, more expensive than 75% of small-cap funds we track.
It returned −4.8% over one year, +5.3% a year over five years, +11.8% a year over ten (as of Dec 31, 2025, per its prospectus).
With $183 million in net assets and 42 holdings, its largest position is Modine Manufacturing Company (11.7%) and the top 10 make up 53.5% of the portfolio.
What stands out
- No front-end sales load
What to watch
- Expensive for its category (1.26%)
- Concentrated: top 10 holdings are 53.5% of assets
Updated Nov 19, 2026
What PVIVX invests in
? The Paradigm Micro-Cap Fund (the Micro-Cap Fund or the Fund) seeks long-term capital appreciation.
Under normal circumstances, the Micro-Cap Fund invests at least 80% of its net assets in the common stocks of U.S. micro-cap companies. The Fund generally considers a company to be a micro-cap company if, at the time of purchase, its market capitalization is within the range of capitalizations of companies in the Russell Microcap Index as of the most recent reconstitution date. As of March 31, 2026, the range of market capitalizations for the Russell Microcap Index was $3 million to $8.937 billion. The capitalizations of companies within the Russell Microcap Index may increase or decrease due to market conditions. The Fund may be overweight in certain sectors at various times. Stocks are sold when they have realized the value anticipated by the Advisor or if new investment opportunities with higher expected returns are acquired. The Fund may continue to hold stocks of companies whose…
From the fund's prospectus (filed Apr 29, 2026).
PVIVX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| PVIVX | −4.8% | +5.3% | +11.8% |
| Small-Cap median | +7.6% | +7.0% | +9.2% |
Source: Fund prospectus, as of Dec 31, 2025
What PVIVX costs
On a $10,000 investment, PVIVX's 1.26% expense ratio costs about $126 a year. The prospectus estimates $1,523 in total costs over 10 years (assuming 5% annual returns). The median small-cap fund charges 0.99%.
PVIVX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Modine Manufacturing Company | 11.65% |
| 2 | Onto Innovation Inc. | 8.25% |
| 3 | Goldman Sachs Trust - Goldman Sachs Financial Square Government Fund Institutional Class | 6.22% |
| 4 | QuidelOrtho Corporation | 4.97% |
| 5 | Veeco Instruments Inc. | 4.13% |
| 6 | Integra Lifesciences Holdings Corporation | 3.92% |
| 7 | A10 Networks, Inc. | 3.83% |
| 8 | The Pennant Group, Inc. | 3.63% |
| 9 | The Ensign Group, Inc. | 3.50% |
| 10 | Build-A-Bear Workshop, Inc. | 3.41% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 53.5% of the fund. See all top 25 holdings and asset mix →